Kan Li

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of diseaseCommunication technology and digital media studiesDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2025
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis.

Yong-Man Kim, Shin Nishio, Se Ik Kim

|Nov 01, 2023
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.

Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari

|Oct 14, 2021
Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease.

Haotian Zou, Kan Li, Donglin Zeng

|Jan 28, 2021
Age-specific social mixing of school-aged children in a US setting using proximity detecting sensors and contact surveys.

Kyra H Grantz, Derek A T Cummings, Shanta Zimmer

|Aug 07, 2019
Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data.

Kan Li, Sheng Luo

|Apr 17, 2019
A Bayesian approach for individual-level drug benefit-risk assessment.

Kan Li, Sheng Luo, Sammy Yuan

Pageof 1

Frequent Collaborators

3 joint publications

Sheng Luo

2 joint publications

Domenica Lorusso

2 joint publications

Bradley J Monk

2 joint publications

Nicoletta Colombo